http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112012018625-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34901c8a3aaeb5d3935907da0162fd2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
filingDate 2010-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0905f7c3a897fff23c561eb00fbd5497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba18b8c21f8e22663ca98399574b9c04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1930493161f667c72cc0f131bcfff3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85f1cbea11c9b3d0eac20e4950200291
publicationDate 2016-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112012018625-A2
titleOfInvention archimica
abstract process for the preparation of lacosamide. A novel process for the synthesis of lacosamide using d, l-serine as a starting material is described, in which the hydroxy methylation reaction is performed using a low cost base such as, and is not a low cost alkylating agent. Toxic and non-carcinogenic, such as methyl ptoluenesulfonate, the r enantiometer is isolated from the racemic mixture of lacosamide after selective hydrolysis of acetamide, salification of the racemic mixture with a chiral acid (hx *) in an organic solvent, decomposition. of the diastereoisomeric mixture, preferably by precipitation of the enantiometer r, and subsequent acetylation of the optically pure intermediate.
priorityDate 2010-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID219078

Total number of triples: 29.